AS Amber Latvijas balzams (BAL1R) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
16 Jun, 2025Executive summary
Net turnover for 2024 was €78.2 million, down 20.1% year-over-year, mainly due to lower order volumes from the largest customer, Stoli Group, which accounted for 40% of total volumes.
Gross profit increased by 13% to €16.3 million, driven by a 25.8% reduction in raw material costs despite lower sales volumes.
Operating profit was €3.6 million, down from €4.2 million in 2023, but the operating margin improved to 4.6% from 4.3%.
Net profit for 2024 was €5.0 million, a slight decrease from €5.16 million in 2023.
Production efficiency measures included renegotiated energy contracts, workforce optimization, and improved equipment effectiveness.
Financial highlights
Revenue: €78.2 million in 2024 vs €97.9 million in 2023 (−20.1% year-over-year).
Gross profit: €16.3 million in 2024 vs €14.4 million in 2023 (+13% year-over-year).
Operating profit: €3.58 million in 2024 vs €4.16 million in 2023.
Net profit: €5.02 million in 2024 vs €5.16 million in 2023.
Earnings per share: €0.67 in 2024 vs €0.69 in 2023.
Outlook and guidance
Focus remains on increasing production efficiency, reducing costs, and improving profitability.
Plans to increase sales volumes and prices to further enhance profitability.
Latest events from AS Amber Latvijas balzams
- Revenue and profit declined amid cost pressures and legal challenges, prompting restructuring.BAL1R
Q4 20252 Mar 2026 - Net profit fell 66% year-over-year to €1.2 million on 7% lower revenue, despite higher volumes.BAL1R
Q3 202529 Nov 2025 - Revenue declined 3.5% but sales volumes rose 10.5%, with net profit at EUR 1.16 million.BAL1R
Q2 20251 Sep 2025 - Net profit more than tripled to €3.6 million as cost savings offset lower sales.BAL1R
Q3 202413 Jun 2025 - Net profit rebounded to €1.47 million in H1 2024 despite a 19.8% revenue decline.BAL1R
Q2 202413 Jun 2025 - Q1 2025 profit rebounded on cost savings despite lower sales; outlook remains positive.BAL1R
Q1 20256 Jun 2025